ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Heparin Sodium API Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-8H8246
Home | Market Reports | Business & Industrial| Chemicals Industry
Global and Japan Heparin Sodium API Market Insights Forecast to 2027
BUY CHAPTERS

Global Heparin Sodium API Market Research Report 2025

Code: QYRE-Auto-8H8246
Report
August 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Opocrin
Pfizer Inc
Aspen Oss
Bioibérica
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Dongying Tiandong Pharmaceutical
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical

Heparin Sodium API Market Size

The global market for Heparin Sodium API was valued at US$ 1129 million in the year 2024 and is projected to reach a revised size of US$ 2146 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Heparin Sodium API Market

Heparin Sodium API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Heparin Sodium API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Heparin sodium API is a polysaccharide biochemical extracted from porcine intestinal mucosa, and it is called "heparin sodium" because it usually exists in the form of its sodium salt.
The Heparin Sodium API market is primarily driven by the growing global demand for anticoagulant therapies in cardiovascular and renal care. Cardiovascular disease remains the leading cause of death worldwide, necessitating large-scale use of heparin in acute coronary syndrome (ACS), myocardial infarction, and during surgical interventions like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Furthermore, the increasing prevalence of chronic kidney disease has led to rising dialysis procedures, where unfractionated heparin remains the standard anticoagulant to prevent clotting in extracorporeal circuits. In addition, the expanding geriatric population, which is more susceptible to thrombosis and atrial fibrillation, further fuels demand for injectable anticoagulants. On the regulatory front, a growing number of approvals for low molecular weight heparin (LMWH) formulations based on Heparin Sodium API — particularly enoxaparin — has encouraged investment by global and regional pharmaceutical manufacturers. The relatively low cost of heparin APIs, combined with established clinical efficacy, supports its continued use in both developed and emerging healthcare systems. Moreover, the concentration of raw material supply and manufacturing capacity in China provides economies of scale and stable global distribution, reinforcing market growth.
Despite favorable demand dynamics, the Heparin Sodium API market faces several critical challenges. First and foremost is the heavy dependence on animal-sourced raw materials, primarily porcine intestinal mucosa. This dependence exposes the supply chain to fluctuations in pig populations, outbreaks of diseases such as African Swine Fever (ASF), and regional farming regulations, all of which can sharply impact availability and pricing. Additionally, the limited number of GMP-compliant manufacturers with international regulatory certifications creates bottlenecks in global supply, especially during periods of surge demand or trade disruption. Another major issue is the strict quality and safety requirements enforced by regulatory authorities like the FDA and EMA, which necessitate extensive purification and viral removal steps, significantly raising production costs and compliance burdens. Lastly, growing competition from synthetic anticoagulants and direct oral anticoagulants (DOACs), which do not rely on animal tissue and offer convenient oral dosing, may gradually erode market share in certain clinical segments. These challenges underscore the need for supply diversification, technological investment, and enhanced global regulatory harmonization.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Heparin Sodium API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Sodium API.
The Heparin Sodium API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin Sodium API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin Sodium API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Heparin Sodium API Market Report

Report Metric Details
Report Name Heparin Sodium API Market
Accounted market size in year US$ 1129 million
Forecasted market size in 2031 US$ 2146 million
CAGR 7.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Production by Region
  • North America
  • Europe
  • China
  • India
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, Aspen Oss, Yino Pharma, Nanjing Xinbai Pharmaceutical, Hubei Enoray Biopharmaceutical, Cisen Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Heparin Sodium API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Heparin Sodium API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Heparin Sodium API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Heparin Sodium API Market growing?

Ans: The Heparin Sodium API Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Heparin Sodium API Market size in 2031?

Ans: The Heparin Sodium API Market size in 2031 will be US$ 2146 million.

Who are the main players in the Heparin Sodium API Market report?

Ans: The main players in the Heparin Sodium API Market are Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, Aspen Oss, Yino Pharma, Nanjing Xinbai Pharmaceutical, Hubei Enoray Biopharmaceutical, Cisen Pharmaceutical

What are the Application segmentation covered in the Heparin Sodium API Market report?

Ans: The Applications covered in the Heparin Sodium API Market report are Cardiovascular Disease, Dialysis Anticoagulation, Postoperative Thrombosis Prevention, Other

What are the Type segmentation covered in the Heparin Sodium API Market report?

Ans: The Types covered in the Heparin Sodium API Market report are Unfractionated Heparin Sodium, Low Molecular Heparin Sodium

Recommended Reports

Heparin API Markets

Anticoagulant Drug Markets

Sodium API Derivatives

1 Heparin Sodium API Market Overview
1.1 Product Definition
1.2 Heparin Sodium API by Type
1.2.1 Global Heparin Sodium API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Unfractionated Heparin Sodium
1.2.3 Low Molecular Heparin Sodium
1.3 Heparin Sodium API by Application
1.3.1 Global Heparin Sodium API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Cardiovascular Disease
1.3.3 Dialysis Anticoagulation
1.3.4 Postoperative Thrombosis Prevention
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Heparin Sodium API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Heparin Sodium API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Heparin Sodium API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Heparin Sodium API Production Market Share by Manufacturers (2020-2025)
2.2 Global Heparin Sodium API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Heparin Sodium API, Industry Ranking, 2023 VS 2024
2.4 Global Heparin Sodium API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Heparin Sodium API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Heparin Sodium API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Heparin Sodium API, Product Offered and Application
2.8 Global Key Manufacturers of Heparin Sodium API, Date of Enter into This Industry
2.9 Heparin Sodium API Market Competitive Situation and Trends
2.9.1 Heparin Sodium API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Heparin Sodium API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Heparin Sodium API Production by Region
3.1 Global Heparin Sodium API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Heparin Sodium API Production Value by Region (2020-2031)
3.2.1 Global Heparin Sodium API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Heparin Sodium API by Region (2026-2031)
3.3 Global Heparin Sodium API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Heparin Sodium API Production Volume by Region (2020-2031)
3.4.1 Global Heparin Sodium API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Heparin Sodium API by Region (2026-2031)
3.5 Global Heparin Sodium API Market Price Analysis by Region (2020-2025)
3.6 Global Heparin Sodium API Production and Value, Year-over-Year Growth
3.6.1 North America Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)
3.6.4 India Heparin Sodium API Production Value Estimates and Forecasts (2020-2031)
4 Heparin Sodium API Consumption by Region
4.1 Global Heparin Sodium API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Heparin Sodium API Consumption by Region (2020-2031)
4.2.1 Global Heparin Sodium API Consumption by Region (2020-2025)
4.2.2 Global Heparin Sodium API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Heparin Sodium API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Heparin Sodium API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Heparin Sodium API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Heparin Sodium API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Heparin Sodium API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Heparin Sodium API Production by Type (2020-2031)
5.1.1 Global Heparin Sodium API Production by Type (2020-2025)
5.1.2 Global Heparin Sodium API Production by Type (2026-2031)
5.1.3 Global Heparin Sodium API Production Market Share by Type (2020-2031)
5.2 Global Heparin Sodium API Production Value by Type (2020-2031)
5.2.1 Global Heparin Sodium API Production Value by Type (2020-2025)
5.2.2 Global Heparin Sodium API Production Value by Type (2026-2031)
5.2.3 Global Heparin Sodium API Production Value Market Share by Type (2020-2031)
5.3 Global Heparin Sodium API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Heparin Sodium API Production by Application (2020-2031)
6.1.1 Global Heparin Sodium API Production by Application (2020-2025)
6.1.2 Global Heparin Sodium API Production by Application (2026-2031)
6.1.3 Global Heparin Sodium API Production Market Share by Application (2020-2031)
6.2 Global Heparin Sodium API Production Value by Application (2020-2031)
6.2.1 Global Heparin Sodium API Production Value by Application (2020-2025)
6.2.2 Global Heparin Sodium API Production Value by Application (2026-2031)
6.2.3 Global Heparin Sodium API Production Value Market Share by Application (2020-2031)
6.3 Global Heparin Sodium API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Shenzhen Hepalink Pharmaceutical
7.1.1 Shenzhen Hepalink Pharmaceutical Heparin Sodium API Company Information
7.1.2 Shenzhen Hepalink Pharmaceutical Heparin Sodium API Product Portfolio
7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Shenzhen Hepalink Pharmaceutical Main Business and Markets Served
7.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
7.2 Yantai Dongcheng Pharmaceutical
7.2.1 Yantai Dongcheng Pharmaceutical Heparin Sodium API Company Information
7.2.2 Yantai Dongcheng Pharmaceutical Heparin Sodium API Product Portfolio
7.2.3 Yantai Dongcheng Pharmaceutical Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Yantai Dongcheng Pharmaceutical Main Business and Markets Served
7.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
7.3 Pfizer
7.3.1 Pfizer Heparin Sodium API Company Information
7.3.2 Pfizer Heparin Sodium API Product Portfolio
7.3.3 Pfizer Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Pfizer Main Business and Markets Served
7.3.5 Pfizer Recent Developments/Updates
7.4 Bioibérica
7.4.1 Bioibérica Heparin Sodium API Company Information
7.4.2 Bioibérica Heparin Sodium API Product Portfolio
7.4.3 Bioibérica Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Bioibérica Main Business and Markets Served
7.4.5 Bioibérica Recent Developments/Updates
7.5 Changzhou Qianhong Biopharma
7.5.1 Changzhou Qianhong Biopharma Heparin Sodium API Company Information
7.5.2 Changzhou Qianhong Biopharma Heparin Sodium API Product Portfolio
7.5.3 Changzhou Qianhong Biopharma Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Changzhou Qianhong Biopharma Main Business and Markets Served
7.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates
7.6 Nanjing King-friend Biochemical Pharmaceutical
7.6.1 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Company Information
7.6.2 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Product Portfolio
7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Nanjing King-friend Biochemical Pharmaceutical Main Business and Markets Served
7.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
7.7 Hebei Changshan Biochemical Pharmaceutical
7.7.1 Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Company Information
7.7.2 Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Product Portfolio
7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served
7.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
7.8 Qingdao Jiulong Biopharmaceutical
7.8.1 Qingdao Jiulong Biopharmaceutical Heparin Sodium API Company Information
7.8.2 Qingdao Jiulong Biopharmaceutical Heparin Sodium API Product Portfolio
7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Qingdao Jiulong Biopharmaceutical Main Business and Markets Served
7.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
7.9 Opocrin
7.9.1 Opocrin Heparin Sodium API Company Information
7.9.2 Opocrin Heparin Sodium API Product Portfolio
7.9.3 Opocrin Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Opocrin Main Business and Markets Served
7.9.5 Opocrin Recent Developments/Updates
7.10 Dongying Tiandong Pharmaceutical
7.10.1 Dongying Tiandong Pharmaceutical Heparin Sodium API Company Information
7.10.2 Dongying Tiandong Pharmaceutical Heparin Sodium API Product Portfolio
7.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Dongying Tiandong Pharmaceutical Main Business and Markets Served
7.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
7.11 Aspen Oss
7.11.1 Aspen Oss Heparin Sodium API Company Information
7.11.2 Aspen Oss Heparin Sodium API Product Portfolio
7.11.3 Aspen Oss Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Aspen Oss Main Business and Markets Served
7.11.5 Aspen Oss Recent Developments/Updates
7.12 Yino Pharma
7.12.1 Yino Pharma Heparin Sodium API Company Information
7.12.2 Yino Pharma Heparin Sodium API Product Portfolio
7.12.3 Yino Pharma Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Yino Pharma Main Business and Markets Served
7.12.5 Yino Pharma Recent Developments/Updates
7.13 Nanjing Xinbai Pharmaceutical
7.13.1 Nanjing Xinbai Pharmaceutical Heparin Sodium API Company Information
7.13.2 Nanjing Xinbai Pharmaceutical Heparin Sodium API Product Portfolio
7.13.3 Nanjing Xinbai Pharmaceutical Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Nanjing Xinbai Pharmaceutical Main Business and Markets Served
7.13.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
7.14 Hubei Enoray Biopharmaceutical
7.14.1 Hubei Enoray Biopharmaceutical Heparin Sodium API Company Information
7.14.2 Hubei Enoray Biopharmaceutical Heparin Sodium API Product Portfolio
7.14.3 Hubei Enoray Biopharmaceutical Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Hubei Enoray Biopharmaceutical Main Business and Markets Served
7.14.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
7.15 Cisen Pharmaceutical
7.15.1 Cisen Pharmaceutical Heparin Sodium API Company Information
7.15.2 Cisen Pharmaceutical Heparin Sodium API Product Portfolio
7.15.3 Cisen Pharmaceutical Heparin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Cisen Pharmaceutical Main Business and Markets Served
7.15.5 Cisen Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Heparin Sodium API Industry Chain Analysis
8.2 Heparin Sodium API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Heparin Sodium API Production Mode & Process Analysis
8.4 Heparin Sodium API Sales and Marketing
8.4.1 Heparin Sodium API Sales Channels
8.4.2 Heparin Sodium API Distributors
8.5 Heparin Sodium API Customer Analysis
9 Heparin Sodium API Market Dynamics
9.1 Heparin Sodium API Industry Trends
9.2 Heparin Sodium API Market Drivers
9.3 Heparin Sodium API Market Challenges
9.4 Heparin Sodium API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Opocrin
Pfizer Inc
Aspen Oss
Bioibérica
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Dongying Tiandong Pharmaceutical
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
List of Tables
 Table 1. Global Heparin Sodium API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Heparin Sodium API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Heparin Sodium API Production Capacity (Kiloton) by Manufacturers in 2024
 Table 4. Global Heparin Sodium API Production by Manufacturers (2020-2025) & (Kiloton)
 Table 5. Global Heparin Sodium API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Heparin Sodium API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Heparin Sodium API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Heparin Sodium API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Heparin Sodium API as of 2024)
 Table 10. Global Market Heparin Sodium API Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Heparin Sodium API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Heparin Sodium API, Product Offered and Application
 Table 13. Global Key Manufacturers of Heparin Sodium API, Date of Enter into This Industry
 Table 14. Global Heparin Sodium API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Heparin Sodium API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Heparin Sodium API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Heparin Sodium API Production Value Market Share by Region (2020-2025)
 Table 19. Global Heparin Sodium API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Heparin Sodium API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Heparin Sodium API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Table 22. Global Heparin Sodium API Production (Kiloton) by Region (2020-2025)
 Table 23. Global Heparin Sodium API Production Market Share by Region (2020-2025)
 Table 24. Global Heparin Sodium API Production (Kiloton) Forecast by Region (2026-2031)
 Table 25. Global Heparin Sodium API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Heparin Sodium API Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Heparin Sodium API Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Heparin Sodium API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Table 29. Global Heparin Sodium API Consumption by Region (2020-2025) & (Kiloton)
 Table 30. Global Heparin Sodium API Consumption Market Share by Region (2020-2025)
 Table 31. Global Heparin Sodium API Forecasted Consumption by Region (2026-2031) & (Kiloton)
 Table 32. Global Heparin Sodium API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kiloton)
 Table 34. North America Heparin Sodium API Consumption by Country (2020-2025) & (Kiloton)
 Table 35. North America Heparin Sodium API Consumption by Country (2026-2031) & (Kiloton)
 Table 36. Europe Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kiloton)
 Table 37. Europe Heparin Sodium API Consumption by Country (2020-2025) & (Kiloton)
 Table 38. Europe Heparin Sodium API Consumption by Country (2026-2031) & (Kiloton)
 Table 39. Asia Pacific Heparin Sodium API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Table 40. Asia Pacific Heparin Sodium API Consumption by Region (2020-2025) & (Kiloton)
 Table 41. Asia Pacific Heparin Sodium API Consumption by Region (2026-2031) & (Kiloton)
 Table 42. Latin America, Middle East & Africa Heparin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kiloton)
 Table 43. Latin America, Middle East & Africa Heparin Sodium API Consumption by Country (2020-2025) & (Kiloton)
 Table 44. Latin America, Middle East & Africa Heparin Sodium API Consumption by Country (2026-2031) & (Kiloton)
 Table 45. Global Heparin Sodium API Production (Kiloton) by Type (2020-2025)
 Table 46. Global Heparin Sodium API Production (Kiloton) by Type (2026-2031)
 Table 47. Global Heparin Sodium API Production Market Share by Type (2020-2025)
 Table 48. Global Heparin Sodium API Production Market Share by Type (2026-2031)
 Table 49. Global Heparin Sodium API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Heparin Sodium API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Heparin Sodium API Production Value Market Share by Type (2020-2025)
 Table 52. Global Heparin Sodium API Production Value Market Share by Type (2026-2031)
 Table 53. Global Heparin Sodium API Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Heparin Sodium API Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Heparin Sodium API Production (Kiloton) by Application (2020-2025)
 Table 56. Global Heparin Sodium API Production (Kiloton) by Application (2026-2031)
 Table 57. Global Heparin Sodium API Production Market Share by Application (2020-2025)
 Table 58. Global Heparin Sodium API Production Market Share by Application (2026-2031)
 Table 59. Global Heparin Sodium API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Heparin Sodium API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Heparin Sodium API Production Value Market Share by Application (2020-2025)
 Table 62. Global Heparin Sodium API Production Value Market Share by Application (2026-2031)
 Table 63. Global Heparin Sodium API Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Heparin Sodium API Price (US$/Ton) by Application (2026-2031)
 Table 65. Shenzhen Hepalink Pharmaceutical Heparin Sodium API Company Information
 Table 66. Shenzhen Hepalink Pharmaceutical Heparin Sodium API Specification and Application
 Table 67. Shenzhen Hepalink Pharmaceutical Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. Shenzhen Hepalink Pharmaceutical Main Business and Markets Served
 Table 69. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
 Table 70. Yantai Dongcheng Pharmaceutical Heparin Sodium API Company Information
 Table 71. Yantai Dongcheng Pharmaceutical Heparin Sodium API Specification and Application
 Table 72. Yantai Dongcheng Pharmaceutical Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Yantai Dongcheng Pharmaceutical Main Business and Markets Served
 Table 74. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
 Table 75. Pfizer Heparin Sodium API Company Information
 Table 76. Pfizer Heparin Sodium API Specification and Application
 Table 77. Pfizer Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Pfizer Main Business and Markets Served
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Bioibérica Heparin Sodium API Company Information
 Table 81. Bioibérica Heparin Sodium API Specification and Application
 Table 82. Bioibérica Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Bioibérica Main Business and Markets Served
 Table 84. Bioibérica Recent Developments/Updates
 Table 85. Changzhou Qianhong Biopharma Heparin Sodium API Company Information
 Table 86. Changzhou Qianhong Biopharma Heparin Sodium API Specification and Application
 Table 87. Changzhou Qianhong Biopharma Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Changzhou Qianhong Biopharma Main Business and Markets Served
 Table 89. Changzhou Qianhong Biopharma Recent Developments/Updates
 Table 90. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Company Information
 Table 91. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Specification and Application
 Table 92. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Nanjing King-friend Biochemical Pharmaceutical Main Business and Markets Served
 Table 94. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
 Table 95. Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Company Information
 Table 96. Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Specification and Application
 Table 97. Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served
 Table 99. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
 Table 100. Qingdao Jiulong Biopharmaceutical Heparin Sodium API Company Information
 Table 101. Qingdao Jiulong Biopharmaceutical Heparin Sodium API Specification and Application
 Table 102. Qingdao Jiulong Biopharmaceutical Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Qingdao Jiulong Biopharmaceutical Main Business and Markets Served
 Table 104. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
 Table 105. Opocrin Heparin Sodium API Company Information
 Table 106. Opocrin Heparin Sodium API Specification and Application
 Table 107. Opocrin Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Opocrin Main Business and Markets Served
 Table 109. Opocrin Recent Developments/Updates
 Table 110. Dongying Tiandong Pharmaceutical Heparin Sodium API Company Information
 Table 111. Dongying Tiandong Pharmaceutical Heparin Sodium API Specification and Application
 Table 112. Dongying Tiandong Pharmaceutical Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Dongying Tiandong Pharmaceutical Main Business and Markets Served
 Table 114. Dongying Tiandong Pharmaceutical Recent Developments/Updates
 Table 115. Aspen Oss Heparin Sodium API Company Information
 Table 116. Aspen Oss Heparin Sodium API Specification and Application
 Table 117. Aspen Oss Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Aspen Oss Main Business and Markets Served
 Table 119. Aspen Oss Recent Developments/Updates
 Table 120. Yino Pharma Heparin Sodium API Company Information
 Table 121. Yino Pharma Heparin Sodium API Specification and Application
 Table 122. Yino Pharma Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Yino Pharma Main Business and Markets Served
 Table 124. Yino Pharma Recent Developments/Updates
 Table 125. Nanjing Xinbai Pharmaceutical Heparin Sodium API Company Information
 Table 126. Nanjing Xinbai Pharmaceutical Heparin Sodium API Specification and Application
 Table 127. Nanjing Xinbai Pharmaceutical Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Nanjing Xinbai Pharmaceutical Main Business and Markets Served
 Table 129. Nanjing Xinbai Pharmaceutical Recent Developments/Updates
 Table 130. Hubei Enoray Biopharmaceutical Heparin Sodium API Company Information
 Table 131. Hubei Enoray Biopharmaceutical Heparin Sodium API Specification and Application
 Table 132. Hubei Enoray Biopharmaceutical Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. Hubei Enoray Biopharmaceutical Main Business and Markets Served
 Table 134. Hubei Enoray Biopharmaceutical Recent Developments/Updates
 Table 135. Cisen Pharmaceutical Heparin Sodium API Company Information
 Table 136. Cisen Pharmaceutical Heparin Sodium API Specification and Application
 Table 137. Cisen Pharmaceutical Heparin Sodium API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. Cisen Pharmaceutical Main Business and Markets Served
 Table 139. Cisen Pharmaceutical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Heparin Sodium API Distributors List
 Table 143. Heparin Sodium API Customers List
 Table 144. Heparin Sodium API Market Trends
 Table 145. Heparin Sodium API Market Drivers
 Table 146. Heparin Sodium API Market Challenges
 Table 147. Heparin Sodium API Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Heparin Sodium API
 Figure 2. Global Heparin Sodium API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Heparin Sodium API Market Share by Type: 2024 VS 2031
 Figure 4. Unfractionated Heparin Sodium Product Picture
 Figure 5. Low Molecular Heparin Sodium Product Picture
 Figure 6. Global Heparin Sodium API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Heparin Sodium API Market Share by Application: 2024 VS 2031
 Figure 8. Application One
 Figure 9. Application Two
 Figure 10. Application Three
 Figure 11. Application Four
 Figure 12. Application Five
 Figure 13. Application Six
 Figure 14. Application Seven
 Figure 15. Application Eight
 Figure 16. Application Nine
 Figure 17. Global Heparin Sodium API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Heparin Sodium API Production Value (US$ Million) & (2020-2031)
 Figure 19. Global Heparin Sodium API Production Capacity (Kiloton) & (2020-2031)
 Figure 20. Global Heparin Sodium API Production (Kiloton) & (2020-2031)
 Figure 21. Global Heparin Sodium API Average Price (US$/Ton) & (2020-2031)
 Figure 22. Heparin Sodium API Report Years Considered
 Figure 23. Heparin Sodium API Production Share by Manufacturers in 2024
 Figure 24. Global Heparin Sodium API Production Value Share by Manufacturers (2024)
 Figure 25. Heparin Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. The Global 5 and 10 Largest Players: Market Share by Heparin Sodium API Revenue in 2024
 Figure 27. Global Heparin Sodium API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 28. Global Heparin Sodium API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 29. Global Heparin Sodium API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Figure 30. Global Heparin Sodium API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 31. North America Heparin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 32. Europe Heparin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 33. China Heparin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 34. India Heparin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 35. Global Heparin Sodium API Consumption by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Figure 36. Global Heparin Sodium API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 37. North America Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 38. North America Heparin Sodium API Consumption Market Share by Country (2020-2031)
 Figure 39. U.S. Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 40. Canada Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 41. Europe Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 42. Europe Heparin Sodium API Consumption Market Share by Country (2020-2031)
 Figure 43. Germany Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 44. France Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 45. U.K. Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 46. Italy Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 47. Russia Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 48. Asia Pacific Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 49. Asia Pacific Heparin Sodium API Consumption Market Share by Region (2020-2031)
 Figure 50. China Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 51. Japan Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 52. South Korea Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 53. China Taiwan Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 54. Southeast Asia Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 55. India Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 56. Latin America, Middle East & Africa Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 57. Latin America, Middle East & Africa Heparin Sodium API Consumption Market Share by Country (2020-2031)
 Figure 58. Mexico Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 59. Brazil Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 60. Turkey Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 61. GCC Countries Heparin Sodium API Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 62. Global Production Market Share of Heparin Sodium API by Type (2020-2031)
 Figure 63. Global Production Value Market Share of Heparin Sodium API by Type (2020-2031)
 Figure 64. Global Heparin Sodium API Price (US$/Ton) by Type (2020-2031)
 Figure 65. Global Production Market Share of Heparin Sodium API by Application (2020-2031)
 Figure 66. Global Production Value Market Share of Heparin Sodium API by Application (2020-2031)
 Figure 67. Global Heparin Sodium API Price (US$/Ton) by Application (2020-2031)
 Figure 68. Heparin Sodium API Value Chain
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Heparin Sodium API and Heparin Calcium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High Purity Heparin Sodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sodium Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heparin Sodium Market Insights Forecast to 2030
Global Heparin Sodium Injection Market Insights Forecast to 2030
Global Heparin Market Insights Forecast to 2030
Global Porcine Heparin APIs Market Research Report 2024
Heparin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enoxaparin Sodium Market Research Report 2024
Global Enoxaparin API Market Research Report 2025
Heparin Heparin Sodium and Heparin Calcium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Low Molecular Weight Heparin Sodium Market Insights Forecast to 2030
Global Heparin Sodium Active Pharmaceutical Ingredient Market Research Report 2024
Global Heparin Anticoagulant Market Insights Forecast to 2028
Global Heparin Sodium Tube Market Research Report 2024
Global Fondaparinux Sodium API Market Research Report 2025
Global Anticoagulant Drugs Market Insights Forecast to 2030
Global Peptide and Heparin Market Research Report 2024
Global Heparin Calcium API Market Research Report 2025
Global Warfarin Sodium Tablets Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions